InvestSMART

Immutep Limited (ASX: IMM) - Announcements

Current share price for IMM : $0.049 0.001 (2%)+

ASX company news and announcements for Immutep Limited (IMM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immutep Limited (IMM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immutep Limited (IMM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immutep Limited (IMM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$72 Change in substantial holding 10 Apr 2026 8:19AM $0.041 $0.049 risen by 19.51%
$72 Immutep Investor Update 8 Apr 2026 10:06AM $0.042 $0.049 risen by 16.67%
$72 Change in substantial holding 20 Mar 2026 8:18AM $0.051 $0.049 fallen by 3.92%
$72 Change in substantial holding 20 Mar 2026 8:18AM $0.051 $0.049 fallen by 3.92%
$72 Ceasing to be a substantial holder from IFL 19 Mar 2026 1:24PM $0.055 $0.049 fallen by 10.09%
$72 Update on Phase I Study of IMP761 for Autoimmune Diseases 19 Mar 2026 8:20AM $0.052 $0.049 fallen by 5.77%
$72 Change in substantial holding 19 Mar 2026 8:19AM $0.052 $0.049 fallen by 5.77%
$72 Change in substantial holding 19 Mar 2026 8:16AM $0.052 $0.049 fallen by 5.77%
$72 Ceasing to be a substantial holder 18 Mar 2026 6:16PM $0.052 $0.049 fallen by 5.77%
$72 Becoming a substantial holder 17 Mar 2026 5:16PM $0.051 $0.049 fallen by 3.92%
$72 Change in substantial holding 17 Mar 2026 8:20AM $0.061 $0.049 fallen by 19.67%
$72 Reinstatement to Quotation 13 Mar 2026 8:57AM $0.395 $0.049 fallen by 87.59%
$72 TACTI-004 to be discontinued following futility analysis 13 Mar 2026 8:57AM $0.395 $0.049 fallen by 87.59%
$72 Suspension from Quotation 11 Mar 2026 9:58AM $0.395 $0.049 fallen by 87.59%
$72 Trading Halt 6 Mar 2026 5:35PM $0.395 $0.049 fallen by 87.59%
$72 Half Yearly Report and Accounts 25 Feb 2026 9:07AM $0.385 $0.049 fallen by 87.27%
$72 Change in substantial holding 11 Feb 2026 8:20AM $0.375 $0.049 fallen by 86.93%
$72 Immutep Achieves 50% Enrolment in Global TACTI-004-1L NSCLC 6 Feb 2026 8:19AM $0.380 $0.049 fallen by 87.11%
$72 Change in substantial holding 5 Feb 2026 8:15AM $0.385 $0.049 fallen by 87.27%
$72 Immutep Quarterly Activities Report and Appendix 4C 29 Jan 2026 11:36AM $0.425 $0.049 fallen by 88.47%
$72 Change in substantial holding 31 Dec 2025 8:27AM $0.430 $0.049 fallen by 88.60%
$72 Positive Update on IMP761 Phase 1 22 Dec 2025 8:25AM $0.395 $0.049 fallen by 87.59%
$72 TACTI-004 phase III trial enrolment continues at robust pace 16 Dec 2025 8:34AM $0.370 $0.049 fallen by 86.76%
$72 Immutep enters into Strategic Collaboration with Dr. Reddy's 8 Dec 2025 6:24PM $0.255 $0.049 fallen by 80.78%
$72 Change of Director's Interest Notice - R Howard 5 Dec 2025 7:34PM $0.260 $0.049 fallen by 81.15%

26 - 50 of 773 results

Page 2 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.